GIMAP6 and metastatic neoplasm: Analyses of patient data from the Cancer Genome Atlas (TCGA) showed that GIMAP6, SAMD9L, and IL27 are significantly upregulated in metastatic tumors compared to the primary lesions, whereas TAP1 was not differentially expressed in patient samples (Fig. 6D).